News

Our Healthcare News

AxoGen, Inc. Announces Proposed Public Offering of Common Stock

ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that…  

Nov 15 2017

EUSA Pharma and AVEO Oncology Announce First Commercial Launch of FOTIVDA (tivozanib)

HEMEL HEMPSTEAD, England & CAMBRIDGE, Massachusetts. – – EUSA Pharma and AVEO Oncology (NASDAQ: AVEO) today announced the first commercial launch of FOTIVDA® (tivozanib) with…  

Nov 15 2017

Grupo Biotoscana Acquires Laboratorio DOSA

Montevideo, Uruguay - - GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced the acquisition of Laboratorio DOSA S.A., a specialty…  

Nov 13 2017

Biotoscana Announces Launch of ABRAXANE/ABRAXUS in Brazil and Mexico

MONTEVIDEO, Uruguay—BIOTOSCANA INVESTMENTS S.A. (“Company” or “GBT”) (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders and the market in general…  

Nov 01 2017

EW Healthcare Partners Announces the Appointment of Three Senior Executives

NEW YORK, New York—EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of three senior…  

Oct 18 2017

AxoGen, Inc. Receives David J. Gury Company of the Year Award from BioFlorida

ALACHUA, Florida (GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, has received the BioFlorida David…  

Oct 18 2017

Grupo Biotoscana and EISAI Sign Licensing Agreement for Four Oncology & Neurology Products in LatAm

MONTEVIDEO, Uruguay and WOODCLIFF LAKE, New Jersey—GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced that it has entered into an…  

Oct 03 2017

Grupo Biotoscana Expands Partnership with Gilead Sciences in HCV in Brazil

Montevideo, Uruguay—GBT-Grupo Biotoscana (B3: GBIO33), a leading specialty pharmaceutical company in Latin America, today announced that it has expanded its partnership with Gilead Sciences (Nasdaq:…  

Aug 30 2017

AxoGen, Inc Reports 2017 Second Quarter Financial Results, Representing 46% Growth over Prior Year

ALACHUA, Fla., (GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and…  

Aug 02 2017



View Legacy Fund news >